Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States ...

Earlier in March 2026, Guardant Health announced that its FDA-approved Shield blood-based colorectal cancer screening test is now widely available for physician order through Quest Diagnostics’ ...

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify ...

July 22 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the ...

Gardner and Wallace will be based in Quest’s Secaucus headquarters, a company representative told NJBIZ. “These latest appointments continue to strengthen Quest’s leadership team and position us well ...

Quest Diagnostics appointed five executives, with one filling a new role for the company. Quest said April 20 that the process to find a successor to retiring executive vice president and CFO Mark ...

Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors ...

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...

(RTTNews) - Quest Diagnostics Incorporated (DGX), a provider of diagnostic information services, Tuesday said it partnered with The University of Texas MD Anderson Cancer Center to develop a ...